The breast cancer epidemic: 10 facts
- PMID: 25249706
- PMCID: PMC4135458
- DOI: 10.1179/2050854914Y.0000000027
The breast cancer epidemic: 10 facts
Abstract
Breast cancer, affecting one in eight American women, is a modern epidemic. The increasing frequency of breast cancer is widely recognized. However, the wealth of compelling epidemiological data on its prevention is generally not available, and as a consequence, is largely unknown to the public. The purpose of this report is to review the epidemiological evidence of preventable causes of breast cancer. [Table: see text].
Keywords: Breast cancer epidemic; Breast cancer susceptibility window; Breast feeding; Delayed childbearing; Hormone replacement therapy; Induced abortion; Levonorgestrel; Oral contraceptives.
References
-
- American Cancer Society. 2012. What are the risk factors for breast cancer? http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-ri.... Rev. December 6, 2012.
-
- Anonymous. 2014. In brief: Testosterone and cardiovascular risk. Med Lett Drugs Ther 56: 17 - PubMed
-
- (The Practice Committee of the) American Society for Reproductive Medicine. 2008. Progesterone supplementation during the luteal phase and in early pregnancy in the treatment of infertility: An educational bulletin. Fertility and Sterility 89: 789–92 - PubMed
-
- Anderson, G.L., Judd H.L., Kaunitz A.M., Barad D.H., Beresford S.A., Pettinger M., Liu J., McNeeley S.G., Lopez A.M.and Women's Health Initiative Investigators . 2003. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: The Women's Health Initiative randomized trial. Journal of the American Medical Association 290: 1739–48 - PubMed
-
- Anderson, G.L., Chlebowski R.T., Aragaki A.K., Kuller L.H., Manson J.E., Gass M., Bluhme E., Connelly S., Hubbell F.A., Lane D., Martin L., Ockene J., Rohan T., Schenken R., and Wactawski-Wende J.. 2012. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: Extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncology 13: 476–86. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
